Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines

Journal of Experimental and Clinical Cancer Research

Volumn 26, Issue 1, 2007, Pages 117-124

  Wang, S P ^a   Zhou, H J ^a   Chen, Xiao Ping ^a   Ren, G Y ^a   Ruan, X X ^a   Zhang, Y ^a   Zhang, R L ^a   Chen, J ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Down regulation; Hepatocellular carcinoma; Kruppel like factor 6

Indexed keywords

MESSENGER RNA; POLYCLONAL ANTIBODY;

ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; KRUPPEL LIKE FACTOR 6 GENE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIVER NEOPLASMS; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 34247525419     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Thorgeirsson S.S., Grisham J.W.: Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. 31:339-346, 2002.
2. Zhang X., Xu H.J., Murakami Y., Sachse R., Yashima K., Hirohashi S., Hu S.X., et al.: Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res. 54:4177-4182, 1994.
3. Ng I.O., Srivastava G., Chung L.P., Tsang S.W., Ng M.M.: Overexpression and point mutations of p53 tumor suppressor gene in hepatocellular carcinomas in Hong Kong Chinese people. Cancer 74:30-37, 1994.
4. Leon M., Kew M.C.: Analysis of ras gene mutations in hepatocellular carcinoma in southern African blacks. Anticancer Res. 15:859-861, 1995.
5. Laub F., Aldabe R., Ramirez F. and Friedman S.: Embryonic expression of Kruppel-like factor 6 in neural and non-neural tissues. Mech. Dev. 106: 167, 2001.
6. Ratziu Y., Lalazar A., Wong L., Dang Q., Collins C., Shaulian E. et al.: Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis. Proc. Natl. Acad. Sci. USA 95: 9500, 1998.
7. Ittmann M.: Allelic loss on chromosome 10 in prostate adenocarcinoma. Cancer Res 56: 2143, 1996.
8. Narla G., Heath K.E., Reeves H.L., Li D., Giono L.E., Kimmelman A.C. et al.: KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science 294:2563-2566, 2001.
9. Reeves H.L., Narla G., Oginbiyi O., Haq A.I., Katz A., Benzeno S. et al.: Kruppel-like factor 6 (KLF6) is a tumor suppressor gene frequently inactivated in colorectal cancer. Gastroenterology 126:1090-1103, 2004.
10. Chen H.K., Liu X.Q., Lin J., Chen T.Y., Feng Q.S., Zeng Y.X.: Mutation analysis of KLF6 gene in human nasopharyngeal carcinomas. Ai Zheng 21: 1047-1050, 2002.
11. Jeng Y.M., Hsu H.C.: KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas. Int. J. Cancer. 105:625-629, 2003.
12. Wikman H., Kettunen E., Seppanen J.K., Karjalainen A., Hollmen J., Anttila S. et al.: Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene 21:5804-5813, 2002.
13. Yamashita K., Upadhyay S., Osada M., Hoque M.O., Xiao Y., Mori M., et al.: Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell. 2:485-495, 2002.
14. Chen C., Hyytinen E.R., Sun X., Helin H.J., Koivisto P.A., Frierson H.F. Jr, et al.: Deletion, mutation, and loss of expression of KLF6 in human prostate cancer. Am. J. Pathol. 162:1349-1354, 2003.
15. Koivisto P.A.:, Hyytinen E.R., Matikainen M., Tammela T.L.J., Ikonen T. and Schleutker J.: Kruppel-like factor 6 germ-line mutations are infrequent in Finnish hereditary prostate cancer. The Journal of Urology 172, 506-507, 2004.
16. Mühlbauer K.R., Gröne H.J., Ernst T., Gröne E., Tschada R., Hergenhahn M. and Hollstein M.:, Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes. British Journal of Cancer 89, 687-690, 2003.
17. Sambrook J., Fritsch E F. and Maniatis T.: Molecular cloning: a laboratory manual. 2rd ed. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 1989.
18. Bustin S.A.: Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. Journal of Molecular Endocrinology 25: 169-193, 2000.
19. Bustin S.A.: Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. Journal of Molecular Endocrinology 29:23-39, 2002.
20. Ginzinger D.G.: Gene quantification using real-time quantitative PCR: An emerging technology hits the mainstream .Experimental Hematology 20: 503-512, 2002.
21. Gygi S.P., Rochon Y., Franza B.R., Aebersold R.: Correlation between protein and mRNA abundance in yeast. Molecular and Cell Biology 19:1720-1730, 1999.
22. Whang Y.E., Wu X., Suzuki H., Reiter R.E., Tran C., Vessella R.L., Said J.W., Isaacs W.B., Sawyers C.L.: Inactivation of the tumor suppressor PTEN/ MMAC1 in advanced human prostate cancer through loss of expression. Proc. Natl. Acad. Sci. USA 95:5246-5250, 1998.